Alzheimer's Dementia Clinical Trial
Official title:
The Effect of Virtual Reality Application on Balance and Gait Speed in Individuals With Alzheimer's Dementia
Verified date | April 2019 |
Source | Kirikkale University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of study is to investigate the effect of virtual reality application on balance and gait speed in individuals with Alzheimer's Dementia.
Status | Completed |
Enrollment | 32 |
Est. completion date | June 6, 2018 |
Est. primary completion date | April 30, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Having mild or moderate severity of AD - Lack of communication difficulties or problems - Volunteering to participate in the study - Cerebrovascular event, - Having disturbing the balance and coordination of neurological disease such as Parkinson, MS, - Mini Mental Test Score, 18 to 24 points from being scored - being 65-80 aged. Exclusion Criteria: - Patients diagnosed with dementia (infection, vascular, hematological diseases), patients who could not be contacted during the follow-up period or who did not come to control, cardiac and cerebrovascular event, - Endocrine disorder, fluid-electrolyte imbalance and infection - Patients with malignancy and malignancy, chemotherapy and radiotherapy, - Patients with delirium or depression - Those with protective sensation loss (those with Semmes-Weinstein Monofilament Thickness 4.56 and above) - patients with lower or upper extremity amputations at any level |
Country | Name | City | State |
---|---|---|---|
Turkey | Kirikkale University | Kirikkale | Fabrikalar Street |
Turkey | Kirikkale Universtiy | Kirikkale | Fabrikalar Street |
Lead Sponsor | Collaborator |
---|---|
Kirikkale University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The Tinetti Gait and Balance Test (TGBT) | TGBT consists of balance and gait subheadings. For balance, there are 13 items, and 9 items for gait. Items are scored as 0 (abnormal), 1 (adaptive) and 2 (normal) for balance, 0 (abnormal), 1 (normal) for gait. The maximum balance score of the patient is 26 and the maximum gait score is 9. Total score (balance + walking) is 35 points. | 15 minute | |
Primary | The 5-times Sit to Stand Test | 5 times sit to stand test is a test that evaluates the functional strength of the lower extremity, balance and fall risk. In order to perform this test, a standard size chair with a stopwatch and a flat back is required. We said to the patient that "Please cross your arms to the other shoulder, and when I say start, sit and stand 5 times in the fastest and straightest way you can". I will measure your time with the stopwatch. The rank of the patients was told to them for sit and stand. In the elderly, if the duration of this period is more than 12 seconds indicated the risk of falling, if it is over 15 seconds, this is an indicator of the presence of a risk of repetitive drop | 1 minute | |
Primary | The Gait Speed Measurement Test (GSMT) | For GSMT, individuals were asked to walk at a speed they wanted on a flat surface of 14 m. Signs were placed on the 2nd and 12th meters of the test area to minimize the speed changes between walking start and walking finish, and to make a more objective measurement. The walking time at this 10-meter distance was measured with the stopwatch and the results were recorded in sec and the walking speed was determined | 5 minute | |
Primary | Mini Mental State Test | It was used to determine the cognitive state before the training. The Mini-Mental State Test was first published by Folstein et al. It consists of eleven items under 5 main headings: orientation, record memory, attention and calculation, recall and language, and the total score is evaluated over 30 points. | 15 minute |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02959502 -
Home-Based CR and tDCS to Enhance Cognition in Persons With Mild Cognitive Impairment and Late Life Depression
|
N/A | |
Completed |
NCT02759887 -
Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)
|
N/A | |
Completed |
NCT01002586 -
Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia
|
N/A | |
Terminated |
NCT02804789 -
European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS)
|
||
Completed |
NCT02190084 -
Repetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia
|
Phase 4 | |
Completed |
NCT01409564 -
Cilostazol Augmentation Study in Dementia
|
Phase 4 | |
Completed |
NCT01608217 -
Delta-THC in Dementia
|
Phase 2 | |
Completed |
NCT04748263 -
Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)
|
||
Recruiting |
NCT01195389 -
Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease
|
N/A | |
Completed |
NCT01585272 -
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
|
Phase 4 | |
Withdrawn |
NCT04812769 -
Electronic Consultation for AD/ADRD Residents Experiencing Infectious Diseases
|
N/A |